@article{57f5c38e5ec047f0ab36484922cc280f,
title = "Alcohol: basic and translational research; 15th annual Charles Lieber &1st Samuel French satellite symposium",
abstract = "The present review is based on the research presented at the symposium dedicated to the legacy of the two scientists that made important discoveries in the field of alcohol-induced liver damage: Professors C.S. Lieber and S.W. French. The invited speakers described pharmacological, toxicological and patho-physiological effects of alcohol misuse. Moreover, genetic biomarkers determining adverse drug reactions due to interactions between therapeutics used for chronic or infectious diseases and alcohol exposure were discussed. The researchers presented their work in areas of alcohol-induced impairment in lipid protein trafficking and endocytosis, as well as the role of lipids in the development of fatty liver. The researchers showed that alcohol leads to covalent modifications that promote hepatic dysfunction and injury. We concluded that using new advanced techniques and research ideas leads to important discoveries in science.",
keywords = "Acetylation, Alcoholic liver disease, Human immunodeficiency virus, Hyaline Bodies, Lipid and protein traffic, Inflammation, Nonalcoholic liver disease, Nutrition, Tissue culture",
author = "Neuman, {Manuela G.} and Seitz, {Helmut K.} and Tuma, {Pamela L.} and Osna, {Natalia A.} and Casey, {Carol A.} and Kharbanda, {Kusum K.} and Cohen, {Lawrence B.} and Malnick, {Steve D.H.} and Raghabendra Adhikari and Ramyajit Mitra and Dagur, {Raghubendra Singh} and Murali Ganesan and Chava Srinivas and {Madan Kumar}, Arumugam and Moses New-Aaron and Larisa Poluektova and Thomes, {Paul G.} and Karuna Rasineni and Mihai Opris and Rolf Teschke",
note = "Funding Information: Dr. Tuma received the funding 2R01 AA017626. Dr. Neuman and Dr. Cohen's work is supported by Mahaffy Gastroenterology Grant , Sunnybrook HSC and In Vitro Drug Safety and Biotechnology, Toronto, ON, Canada. Funding Information: Dr. Kharbanda's work was supported by the National Institutes of Health grant R01 AA026723 (KKK) and Merit Review grant BX004053 (KKK) from the U.S. Department of Veterans Affairs , Biomedical Laboratory Research and Development Service . Dr. Osna's study is funded by NIAAA/ AIDS Program : R01AA027189 ; Dr. Casey's work was supported by NIH/NIAAA , R01 AA020735-08/01/11-06/30/26 and I01BX004171 , Department of Veterans' Affairs Merit Award. Funding Information: Dr. Kharbanda's work was supported by the National Institutes of Health grant R01 AA026723 (KKK) and Merit Review grant BX004053 (KKK) from the U.S. Department of Veterans Affairs, Biomedical Laboratory Research and Development Service. Dr. Osna's study is funded by NIAAA/ AIDS Program: R01AA027189; Dr. Casey's work was supported by NIH/NIAAA, R01 AA020735-08/01/11-06/30/26 and I01BX004171, Department of Veterans' Affairs Merit Award.Dr. Tuma received the funding 2R01 AA017626. Dr. Neuman and Dr. Cohen's work is supported by Mahaffy Gastroenterology Grant, Sunnybrook HSC and In Vitro Drug Safety and Biotechnology, Toronto, ON, Canada. Publisher Copyright: {\textcopyright} 2022 Elsevier Inc.",
year = "2022",
month = jun,
doi = "10.1016/j.yexmp.2022.104750",
language = "English (US)",
volume = "126",
journal = "Experimental and Molecular Pathology",
issn = "0014-4800",
publisher = "Academic Press Inc.",
}